Correlation Between Graphite Bio and Magenta Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Graphite Bio and Magenta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Graphite Bio and Magenta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Graphite Bio and Magenta Therapeutics, you can compare the effects of market volatilities on Graphite Bio and Magenta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Graphite Bio with a short position of Magenta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Graphite Bio and Magenta Therapeutics.

Diversification Opportunities for Graphite Bio and Magenta Therapeutics

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Graphite and Magenta is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Graphite Bio and Magenta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Magenta Therapeutics and Graphite Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Graphite Bio are associated (or correlated) with Magenta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Magenta Therapeutics has no effect on the direction of Graphite Bio i.e., Graphite Bio and Magenta Therapeutics go up and down completely randomly.

Pair Corralation between Graphite Bio and Magenta Therapeutics

If you would invest  82.00  in Magenta Therapeutics on September 1, 2024 and sell it today you would earn a total of  0.00  from holding Magenta Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Graphite Bio  vs.  Magenta Therapeutics

 Performance 
       Timeline  
Graphite Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Graphite Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Graphite Bio is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
Magenta Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Magenta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Magenta Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Graphite Bio and Magenta Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Graphite Bio and Magenta Therapeutics

The main advantage of trading using opposite Graphite Bio and Magenta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Graphite Bio position performs unexpectedly, Magenta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Magenta Therapeutics will offset losses from the drop in Magenta Therapeutics' long position.
The idea behind Graphite Bio and Magenta Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume